Goldman Sachs Group Inc Burning Rock Biotech LTD Transaction History

Goldman Sachs Group Inc

  • $605 Billion
  • Q3 2024

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

May 14, 2024
BUY
$1.73 - $2.95 $95,931 - $163,583
55,452 New
55,452 $124,000
Q4 2022

Feb 13, 2023
BUY
$1.73 - $2.95 $95,931 - $163,583
55,452 New
55,452 $124,000
Q1 2022

May 16, 2022
SELL
$6.7 - $10.23 $272,422 - $415,951
-40,660 Closed
0 $0
Q4 2021

Feb 14, 2022
SELL
$9.43 - $17.14 $386,875 - $703,185
-41,026 Reduced 50.22%
40,660 $387,000
Q3 2021

Nov 10, 2021
BUY
$17.37 - $27.92 $1.42 Million - $2.28 Million
81,686 New
81,686 $1.46 Million

Others Institutions Holding BNR

# of Institutions
1
Shares Held
21.2K
Call Options Held
0
Put Options Held
0
View Full List

About Burning Rock Biotech Ltd

BNR Quotes by TradingView
  • Ticker BNR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 105,188,000
  • Market Cap $721M
  • Description
  • Burning Rock Biotech Limited primarily develops and provides cancer therapy selection tests in the People's Republic of China. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company primarily offers next-generation sequencing-based cancer therapy selection and p...
More about BNR
Track This Portfolio

Track Goldman Sachs Group Inc Portfolio

Follow Goldman Sachs Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Goldman Sachs Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Goldman Sachs Group Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email